Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 17-beta-hydroxysteroid dehydrogenase type 2 | ||
Ligand | BDBM50385878 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_823597 (CHEMBL2044598) | ||
IC50 | 391±n/a nM | ||
Citation | Henn, C; Einspanier, A; Marchais-Oberwinkler, S; Frotscher, M; Hartmann, RW Lead optimization of 17ß-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis. J Med Chem55:3307-18 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
17-beta-hydroxysteroid dehydrogenase type 2 | |||
Name: | 17-beta-hydroxysteroid dehydrogenase type 2 | ||
Synonyms: | 17-beta-Hydroxysteroid Dehydrogenase 2 (17-beta-HSD2) | 20 alpha-hydroxysteroid dehydrogenase | 20-alpha-HSD | DHB2_HUMAN | EDH17B2 | Estradiol 17-beta-dehydrogenase 2 | Estradiol 17-beta-dehydrogenase 2 (17beta-HSD2) | HSD17B2 | Microsomal 17-beta-hydroxysteroid dehydrogenas | SDR9C2 | Testosterone 17-beta-dehydrogenase | ||
Type: | Oxidoreductase; single-pass type II membrane protein | ||
Mol. Mass.: | 42795.29 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Enzyme was partially purified from human placenta. | ||
Residue: | 387 | ||
Sequence: |
| ||
BDBM50385878 | |||
n/a | |||
Name | BDBM50385878 | ||
Synonyms: | CHEMBL2040856 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H21NO4S | ||
Mol. Mass. | 491.557 | ||
SMILES | Oc1cccc(c1)-c1ccc2c(c(O)ccc2c1)-c1cccc2n(ccc12)S(=O)(=O)c1ccccc1 |(4.01,8.19,;4.01,6.65,;5.34,5.88,;5.34,4.34,;4,3.57,;2.67,4.34,;2.67,5.88,;1.33,3.57,;1.33,2.03,;-0,1.27,;-1.34,2.04,;-2.67,1.27,;-4,2.04,;-5.34,1.27,;-4,3.58,;-2.67,4.35,;-1.33,3.58,;0,4.35,;-2.67,-.27,;-4.01,-1.04,;-4.01,-2.58,;-2.68,-3.35,;-1.34,-2.58,;.12,-3.06,;1.03,-1.82,;.13,-.57,;-1.34,-1.04,;.6,-4.53,;1.93,-3.76,;1.93,-5.3,;-.49,-5.61,;-1.98,-5.22,;-3.07,-6.3,;-2.67,-7.79,;-1.18,-8.19,;-.09,-7.1,)| | ||
Structure |